Q1 FY27 Profit Jumps 459% on Exceptional Gain, Revenue Declines 8%
Hester Biosciences Limited · HESTERBIO · NSE ·
**Profit Surge**: Consolidated Profit After Tax (PAT) soared 459% year-over-year to ₹967.32 million, driven by a significant one-time gain. **Exceptional Item**: The company recognized an exceptional gain of ₹853.49 million from a loan restructuring with the Gates Foundation for…